PMC3891387_01
Endoscopic retrograde pancreatogram that was done at the first attack. It showed diffuse irregular narrowing of the main pancreatic duct.
kjim-20-163-g001.jpg
PMC3891387_01_kjim-20-163-g001.jpg
F1
An ERCP showed diffuse, irregular narrowing of the main pancreatic duct (Figure 1) and narrowing of the intrapancreatic common bile duct.
Endoscopic retrograde pancreatogram that was done 3 months after steroid treatment. Here the narrowing of the main pancreatic duct had been ameliorated by steroid treatment.
kjim-20-163-g002.jpg
PMC3891387_01_kjim-20-163-g002.jpg
F2
Three months after treatment with prednisolone (40 mg/day), a follow-up ERCP showed dramatic improvement of the narrowing (Figure 2) of both the main pancreatic duct and the common bile duct.
Endoscopic retrograde pancreatogram (arrows) that was done on relapse. It showed the segmental irregular narrowing of the main pancreatic duct in the tail portion.
kjim-20-163-g003.jpg
PMC3891387_01_kjim-20-163-g003.jpg
F3
The ERCP showed segmental irregular narrowing of the main pancreatic duct in the tail portion (Figure 3) and the narrowing of the intrapancreatic common bile duct.
Endoscopic retrograde pancreatogram that was done 3 months after re-treatment with high dose steroid. The segmental irregular narrowing of the main pancreatic duct in the tail portion was again improved.
kjim-20-163-g004.jpg
PMC3891387_01_kjim-20-163-g004.jpg
F4
A follow-up ERCP demonstrated obvious improvement for the narrowing of both the main pancreatic duct (Figure 4) and the common bile duct.